A study published in Lancet HIV Thursday showed that patients who received gender-affirming hormones were 37% less likely to ...

Click to share on Facebook (Opens in new window) Click to share on X (Opens in new window) Youngkin signed 1st batch of 180 bills. Here are the highlights. Youngkin signed 1st batch of 180 bills ...

An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety trial, researchers report in The Lancet medical journal. Lenacapavir stops ...

An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety trial, researchers report in The Lancet, external medical journal.

The cuts affect a wide range of programs -- from HIV treatment and malaria prevention in Africa to maternal health care in Nepal. “People will die, but we will never know, because even the ...

Those included many that were initially covered by waivers such as work addressing HIV as well as wider health programmes. It is unclear whether the projects can be reinstated. Major United ...